Literature DB >> 15933264

Induced spreading depression activates persistent neurogenesis in the subventricular zone, generating cells with markers for divided and early committed neurons in the caudate putamen and cortex.

Hiroji Yanamoto1, Susumu Miyamoto, Norimitsu Tohnai, Izumi Nagata, Jing-Hui Xue, Yoshikazu Nakano, Yukako Nakajo, Haruhiko Kikuchi.   

Abstract

BACKGROUND AND
PURPOSE: Status epilepticus and cerebral ischemia stimulate persistent neurogenesis in the adult brain, but both conditions cause neuronal damage. We determined whether spreading depression, a common epiphenomenon of these conditions, stimulates persistent neurogenesis.
METHODS: We analyzed the effect of KCl-induced spreading depression on persistent neurogenesis and the spatio-temporal distribution of cells exhibiting immunohistochemical markers for divided and early committed neurons (new neurons) in the adult rat brain.
RESULTS: After induction of spreading depression for 48 hours, the density of mitotic cells, divided cells, and new neurons in the subventricular zone increased at days 1 to 3, days 3 to 6, and day 6, respectively (P<0.05). The divided cell density in the rostral migratory stream and the stream size increased at day 12 (P<0.001). Vehicle (saline) infusion or induction of spreading depression for 4 hours only did not increase the divided cell density, but the latter increased new neuron density in the subventricular zone (P<0.001). Double-labeled new neuron-like cells also appeared in the caudate putamen or cortex in ectopic fashion at day 3, with dramatic increases at days 6 and 12. Administration of the NMDA receptor antagonist, MK-801, which inhibits the propagation of spreading depression, abolished the increase in new neurons in the subventricular zone and the appearance of ectopic new neuron-like cells after 48-hour KCl infusion. There was no neuronal damage, as evidenced by mature neuron density, neurite density, and apoptotic cell appearance after spreading depression for 48 hours.
CONCLUSIONS: Spreading depression has the potential to stimulate persistent neurogenesis or to produce ectopic new neuron-like cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15933264     DOI: 10.1161/01.STR.0000169903.09253.c7

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  23 in total

1.  Cortical spreading depression shifts cell fate determination of progenitor cells in the adult cortex.

Authors:  Yasuhisa Tamura; Asami Eguchi; Guanghua Jin; Mustafa M Sami; Yosky Kataoka
Journal:  J Cereb Blood Flow Metab       Date:  2012-07-11       Impact factor: 6.200

2.  Experimental and preliminary clinical evidence of an ischemic zone with prolonged negative DC shifts surrounded by a normally perfused tissue belt with persistent electrocorticographic depression.

Authors:  Ana I Oliveira-Ferreira; Denny Milakara; Mesbah Alam; Devi Jorks; Sebastian Major; Jed A Hartings; Janos Lückl; Peter Martus; Rudolf Graf; Christian Dohmen; Georg Bohner; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-24       Impact factor: 6.200

Review 3.  Relevance of cortical thickness in migraine sufferers.

Authors:  Nouchine Hadjikhani
Journal:  Expert Rev Neurother       Date:  2008-03       Impact factor: 4.618

Review 4.  Clinical relevance of cortical spreading depression in neurological disorders: migraine, malignant stroke, subarachnoid and intracranial hemorrhage, and traumatic brain injury.

Authors:  Martin Lauritzen; Jens Peter Dreier; Martin Fabricius; Jed A Hartings; Rudolf Graf; Anthony John Strong
Journal:  J Cereb Blood Flow Metab       Date:  2010-11-03       Impact factor: 6.200

5.  Cortical spreading depolarization stimulates gliogenesis in the rat entorhinal cortex.

Authors:  Anja Urbach; Judith Brueckner; Otto W Witte
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-31       Impact factor: 6.200

Review 6.  The continuum of spreading depolarizations in acute cortical lesion development: Examining Leão's legacy.

Authors:  Jed A Hartings; C William Shuttleworth; Sergei A Kirov; Cenk Ayata; Jason M Hinzman; Brandon Foreman; R David Andrew; Martyn G Boutelle; K C Brennan; Andrew P Carlson; Markus A Dahlem; Christoph Drenckhahn; Christian Dohmen; Martin Fabricius; Eszter Farkas; Delphine Feuerstein; Rudolf Graf; Raimund Helbok; Martin Lauritzen; Sebastian Major; Ana I Oliveira-Ferreira; Frank Richter; Eric S Rosenthal; Oliver W Sakowitz; Renán Sánchez-Porras; Edgar Santos; Michael Schöll; Anthony J Strong; Anja Urbach; M Brandon Westover; Maren Kl Winkler; Otto W Witte; Johannes Woitzik; Jens P Dreier
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

7.  Focal cerebral ischemia induces a multilineage cytogenic response from adult subventricular zone that is predominantly gliogenic.

Authors:  Lu Li; Kate M Harms; P Britten Ventura; Diane C Lagace; Amelia J Eisch; Lee Anna Cunningham
Journal:  Glia       Date:  2010-10       Impact factor: 7.452

8.  Microvascular cerebral blood flow fluctuations in association with apneas and hypopneas in acute ischemic stroke.

Authors:  Clara Gregori-Pla; Raquel Delgado-Mederos; Gianluca Cotta; Giacomo Giacalone; Federica Maruccia; Stella Avtzi; Luís Prats-Sánchez; Alejandro Martínez-Domeño; Pol Camps-Renom; Joan Martí-Fàbregas; Turgut Durduran; Mercedes Mayos
Journal:  Neurophotonics       Date:  2019-04-23       Impact factor: 3.593

9.  Structural abnormalities in the thalamus of migraineurs with aura: a multiparametric study at 3 T.

Authors:  Cristina Granziera; Alessandro Daducci; David Romascano; Alexis Roche; Gunther Helms; Gunnar Krueger; Nouchine Hadjikhani
Journal:  Hum Brain Mapp       Date:  2013-03-01       Impact factor: 5.038

10.  Spreading depolarizations cycle around and enlarge focal ischaemic brain lesions.

Authors:  Hajime Nakamura; Anthony J Strong; Christian Dohmen; Oliver W Sakowitz; Stefan Vollmar; Michael Sué; Lutz Kracht; Parastoo Hashemi; Robin Bhatia; Toshiki Yoshimine; Jens P Dreier; Andrew K Dunn; Rudolf Graf
Journal:  Brain       Date:  2010-05-26       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.